Moyamoya disease is an idiopathic chronically progressive cerebrovascular disease, which
causes both ischemic and hemorrhagic stroke. Genetic studies identified RNF213/Mysterin …

Direct superficial temporal artery (STA) to middle cerebral artery (MCA) anastomosis
combined with indirect pial synangiosis provides favorable surgical collaterals for …

OBJECTIVE Although many studies have analyzed risk factors for contralateral progression
in unilateral moyamoya disease, they have not been fully elucidated. The aim of this study …

OBJECTIVE This study was designed to identify predictive factors associated with
substantial contralateral progression in adult patients with bilateral nonhemorrhagic …

Moyamoya arteriopathy (MA) is a rare cerebrovascular disorder characterized by
ischemic/hemorrhagic strokes. The pathophysiology is unknown. A deregulation of …

Background The efficacy of indirect revascularization vs. non-surgical treatment in adults
with Moyamoya disease (MMD) and Moyamoya syndrome (MMS) remains controversial …

Objective This study aimed to explore the long-term outcome of unilateral moyamoya
disease and predict the clinical and genetic factors associated with contralateral progression …

Background Early‐stage unilateral moyamoya disease (MMD) is difficult to discriminate from
isolated intracranial atherosclerotic stenosis, and identification of contralateral progression …

The safety and efficacy of coronavirus disease 2019 (COVID-19) vaccination in patients
diagnosed with Moyamoya disease (MMD) have not been established. Using National …

Unilateral moyamoya disease (U-MMD) is a chronic vascular disease characterized by
progressive stenosis and occlusion of the terminal end of the internal carotid artery and its …